Announcement under Regulation 30 (LODR)-Allotment
Filed with BSE · · 4 pages · English
Summary by 6ix AI
This allotment was made in accordance with prior approvals from shareholders and the stock exchange, with the shares ranking equally with existing shares. Further disclosures required under SEBI regulations are included in the filing as annexures.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Subject: Outcome of the Board Meeting held on Friday, October 16, 2026. The allotment has been made for cash, upon the receipt of the remaining exercise price of Rs. 31.6875/- per share warrant [being an amount equivalent to the 75% of the warrant issue price, i.e. Rs. 42.25/- per warrant (including premium of Rs. 32.25/- per warrant)], aggregating to Rs. 14,734,687.50 /-. The equity shares allott
Earlier from Shelter Pharma
- Board Meeting Outcome for Outcome Of The Board Meeting Held On Friday, October 16, 2026 For Conversion Of Warrants Into Equity Shares
- Shelter Pharma Ltd. Press Release Sep 29 2026
- Shelter Pharma Ltd. Press Release Sep 23 2026
- Shelter Pharma Ltd. Press Release Sep 07 2026
- Shelter Pharma Ltd. Press Release Sep 01 2026
Follow Shelter Pharma into a list and get an email when it puts out news.
Follow Shelter Pharma